CIK 0001658551
- Non-accelerated filer
- Smaller reporting company
Amylyx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMLX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464600503
- Phone
- +1 617-682-0917
- Business address
- 55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,951,125
- in 9 filings, $8.0M under 10b5-1 plans
Net −$10,951,125. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Cohen Joshua B −$4.0M Co-Chief Executive Officer sold 4% of stake
- Klee Justin B. −$4.0M Co-Chief Executive Officer sold 4% of stake
- FRATES JAMES M −$1.6M Chief Financial Officer sold 18% of stake
- MILNE GEORGE M JR −$831K Director sold 4% of stake
- Bedrosian Camille L −$325K Chief Medical Officer sold 3% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-09 | Mazzariello Gina Chief Legal Officer | Sale 10b5-1 | −15,000 | $18.32 | $275K | 194,090 |
| 2026-03-02 | Klee Justin B. Co-Chief Executive Officer | Sale | −29,282 | $14.47 | $424K | 3,334,616 |
| 2026-03-02 | Cohen Joshua B Co-Chief Executive Officer | Sale | −29,282 | $14.48 | $424K | 3,334,683 |
| 2026-03-02 | Bedrosian Camille L Chief Medical Officer | Sale | −6,461 | $14.58 | $94K | 169,295 |
| 2026-03-02 | FRATES JAMES M Chief Financial Officer | Sale | −7,909 | $14.52 | $115K | 165,638 |
| 2026-03-02 | Mazzariello Gina Chief Legal Officer | Sale | −6,844 | $14.52 | $99K | 134,430 |
| 2026-02-23 | Mazzariello Gina Chief Legal Officer | Sale | −3,419 | $14.14 | $48K | 141,274 |
| 2026-02-02 | FRATES JAMES M Chief Financial Officer | Sale | −3,557 | $14.65 | $52K | 173,547 |
| 2026-02-02 | Cohen Joshua B Co-Chief Executive Officer | Sale | −15,500 | $14.68 | $228K | 3,363,965 |
| 2026-02-02 | Mazzariello Gina Chief Legal Officer | Sale | −3,448 | $14.65 | $51K | 144,693 |
| 2026-02-02 | Klee Justin B. Co-Chief Executive Officer | Sale | −15,500 | $14.69 | $228K | 3,363,898 |
| 2026-01-16 | Cohen Joshua B Co-Chief Executive Officer | Sale | −1,974 | $13.83 | $27K | 3,379,465 |
| 2026-01-16 | Klee Justin B. Co-Chief Executive Officer | Sale | −1,995 | $13.89 | $28K | 3,379,398 |
| 2026-01-15 | Cohen Joshua B Co-Chief Executive Officer | Sale | −136,193 | $13.59 | $1.9M | 3,378,621 |
| 2026-01-15 | Klee Justin B. Co-Chief Executive Officer | Sale | −136,193 | $13.58 | $1.8M | 3,378,546 |
| 2026-01-06 | FRATES JAMES M Chief Financial Officer | Sale | −3,326 | $11.11 | $37K | 177,104 |
| 2026-01-06 | Cohen Joshua B Co-Chief Executive Officer | Sale | −7,715 | $11.09 | $86K | 3,317,632 |
| 2026-01-06 | Klee Justin B. Co-Chief Executive Officer | Sale | −7,715 | $11.09 | $86K | 3,317,586 |
| 2025-12-01 | Bedrosian Camille L Chief Medical Officer | Sale | −6,580 | $14.35 | $94K | 175,756 |
| 2025-09-30 | Klee Justin B. Co-Chief Executive Officer | Sale | −29,775 | $14.37 | $428K | 3,325,501 |
Page 2 of 8 · 145 trades